Russia’s role in global affairs has always been significant, but recent years have seen the country emerge at the forefront of geopolitical tension, sparking debates over its internal policies, international ambitions, and the sustainability of its influence in an evolving world. With its vast natural resources, military might, and a
Russia has created fertile ground for local industries to flourish by fostering collaborations between domestic enterprises and foreign investors. Earlier this month S&P Global Manufacturing noted Russia’s manufacturing sector grew to Purchasing Managers Index (PMI) 53.1 in January 2025, from 50.8 in December 2024. This is the fourth consecutive month
Europe’s geopolitical landscape is shifting dramatically, with US President Donald Trump recalibrating America’s stance toward Russia. Since taking office, Trump’s administration has disbanded Biden-era programs aimed at seizing assets from Russian oligarchs, paused military aid to Ukraine, suspended US cyber operations against Russia, and pursued direct negotiations with Russian President,
For Vladimir Putin, the Black Sea isn’t just a body of water, it’s a strategic playground, a historical trophy, and the key to Russia’s ambitions on the world stage. It’s no surprise that he’s clung to Crimea like a jealous lover, positioning his beloved Black Sea Fleet like a well-sharpened
Russia’s pharmaceutical market offers a wealth of untapped potential, particularly for countries in the Global South, BRICS nations, and strategic partners like Iran. As the industry evolves, aligning with Russia’s ambitious goals and navigating its challenges could yield substantial benefits for all stakeholders. In 2023, the Russian pharmaceutical market was
